- 专利标题: Methods of making multispecific antigen-binding molecules
-
申请号: US16097108申请日: 2017-04-28
-
公开(公告)号: US11352446B2公开(公告)日: 2022-06-07
- 发明人: Katherine Cygnar , Frank Delfino
- 申请人: REGENERON PHARMACEUTICALS, INC.
- 申请人地址: US NY Tarrytown
- 专利权人: REGENERON PHARMACEUTICALS, INC.
- 当前专利权人: REGENERON PHARMACEUTICALS, INC.
- 当前专利权人地址: US NY Tarrytown
- 代理机构: FisherBroyles, LLP
- 代理商 Rita S. Wu; Todd R. Samelman
- 国际申请: PCT/US2017/030250 WO 20170428
- 国际公布: WO2017/190079 WO 20171102
- 主分类号: C40B30/04
- IPC分类号: C40B30/04 ; C07K16/46 ; C07K16/12 ; C07K16/28 ; C07K16/44
摘要:
The present invention provides multispecific antigen-binding molecules and methods of making or selecting same. The multispecific antigen-binding molecules comprise a first antigen-binding domain that specifically binds a target molecule, and a second antigen-binding domain that specifically binds an internalizing effector protein. The multispecific antigen-binding molecules of the present invention can, in some embodiments, be bispecific antibodies that are capable of binding both a target molecule and an internalizing effector protein. In certain embodiments of the invention, the simultaneous binding of the target molecule and the internalizing effector protein by the multispecific antigen-binding molecule of the present invention results in the attenuation of the activity of the target molecule to a greater extent than the binding of the target molecule alone. In other embodiments of the invention, the target molecule is a tumor associated antigen, and the simultaneous binding of the tumor associated antigen and the internalizing effector protein by the multispecific antigen-binding molecule of the present invention causes or facilitates the targeted killing of tumor cells.
公开/授权文献
信息查询